1-20 of 2191 < first | prev | | last >
  • Insuring Pharma's Reputation

    When corporate reputations are attacked, personal risk to pharma leaders rises.

    Dr. Nir Kossovsky, CEO, Steel City Re
  • Pallet Type Matters

    Are your pallet choices aiding or thwarting your facility’s sanitation efforts?

    Peter Connors, founder, Remcon Plastics Inc.
  • Tech Transfer: Let’s Take It from the Top

    Why starting with a top-down approach to process definition and automation means better results at the bottom

    Bob Lenich, Life Science Business Director, and Bruce Greenwald, Platform Business Manager, Emerson Automation solutions
  • Cocktails and Murder

    The same public that’s outraged over drug prices spends almost three times as much on booze

  • Bridging the Communication Gap Between QC and Production

    An electronic environmental monitoring system that can seamlessly integrate with the LIMS used by different teams can improve organizational efficiency

    Sinéad Cowman, EU business development manager, Informatics, Lonza
  • True Continuous Manufacturing

    It’s time to replace the pharma industry’s conventional batch-based processing with efficient, true continuous manufacturing.

    Babu Padmanabhan, Ph.D., managing director & chief knowledge officer, STEERLife
  • Pharma Stays on Track

    Respondents to our 13th annual Career and Salary Survey find stability and satisfaction despite increased workloads and changing market conditions.

    Karen Langhauser, Chief Content Director
  • Misplaced Aim: Drug Pricing Scrutiny

    Targeted for its pricing practices, the pharmaceutical industry continues its level-headed drive toward efficiency.

    Karen Langhauser, Chief Content Director
  • Purple Rain and Opioid Awareness

    The FDA has taken several actions to help reduce the number of people who become addicted, or who ultimately overdose from prescription opioids

  • Next-Generation Analytics: Actionable Insights on Tap

    On-demand access to the latest business intelligence is the key to almost every strategic priority life sciences organizations are working towards. But it can’t be delivered without the right groundwork.

    Elvis Paćelat, VP of Compliance Management, AMPLEXOR
  • No Easy Answers for Drug Pricing

    Improving manufacturing efficiencies offers most concrete possibilities for cost reduction

    Jerry Martin, pharmaceutical and life sciences consultant, PMMI
  • The Evolving Biopharma Contract-Manufacturing Market

    Once biopharma companies optimize operations in order to free up hidden capacity, they have four options: build, acquire, partner or face the realities of outsourcing

    Andrea Gennari, Martin Loesch, Alberto Santagostino and Ralf Otto, McKinsey & Co.
  • Inking the Deal

    Mastering the art of lasting outsourcing relationships in the pharmaceutical industry

    Karen Langhauser, Chief Content Director
  • FDA Gathers Faster Drug Data

    FDA implements initiatives to speed drug approvals, labeling changes and delivery

    Katie Weiler, Managing Editor
1-20 of 2191 < first | prev | | last >